Top compounds associated with response to SHMT2


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel CCLE pan-cancer AAC 0.21 1e-05
mRNA FK866 GDSC1000 pan-cancer AAC 0.13 4e-05
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.13 9e-05
mRNA brivanib CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.12 0.0002
mRNA nelarabine CTRPv2 pan-cancer AAC -0.16 0.0002
mRNA SNX-2112 GDSC1000 pan-cancer AAC 0.11 0.0004
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.13 0.0004
mRNA Mitomycin-C GDSC1000 pan-cancer AAC 0.13 0.0004
mRNA TW 37 GDSC1000 pan-cancer AAC 0.11 0.001
Download CSV